Changes in plasma catecholamine concentration and cyclic AMP secretion following beta-blockade in essential hypertension
Brecht, H.M.; Vlachoyannis, J.; Musil, H.A.; Ernst, W.; Weismüller, G.; Schoeppe, W.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1035-1038
1975
ISSN/ISBN: 0070-4067 PMID: 180718 Document Number: 91972
Document emailed within 1 workday
Related Documents
Planz, G.; Corr, H.; Gierlichs, H.W.; Hawlina, A.; Planz, R.; Stephany, W.; Rahn, K.H. 1975: Dopamine-beta-hydroxylase activity and catecholamine concentration in plasma as a parameter of sympathetic tonus: effect of the ergometric test on patients with normotension and essential hypertension Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1066-1068Rahn, K.H. 1980: The influence of beta receptor blocking drugs on plasma catecholamine levels in patients with essential hypertension Archives Internationales de Pharmacodynamie et de Therapie Suppl: 54-57
Lang, R. 1980: Balance of noradrenaline and sodium during chronic beta-receptor blockade in patients with essential hypertension Archives Internationales de Pharmacodynamie et de Therapie Suppl: 67-75
Shiotani, M.; Arita, M.; Nakatsu, C.; Nakamura, N.; Ohshika, H.; Nakamura, Y.; Fujiwara, S.; Ueno, Y.; Nishio, I.; Masuyama, Y. 1990: Effects of calcium antagonists or beta-blockade on left ventricular diastolic function in essential hypertension Journal of Cardiology 20(1): 135-145
Marshall, A.J.; Barritt, D.W.; Harry, J.D. 1977: Dose response and frequency of administration of atenolol in essential hypertension--once daily treatment with beta-blockade Postgraduate Medical Journal 53(Suppl): 168-172
Kolloch, R.; Stumpe, K.O.; Higuchi, M.; Vetter, H.; Glänzer, K.; Krück, F. 1977: Elevated plasma prolactin concentration in essential hypertension Verhandlungen der Deutschen Gesellschaft für Innere Medizin 83: 296-298
Planz, G.; Haass, H.; Lamberts, B. 1982: Plasma catecholamine concentration in hypertensive subjects with chronic renal failure before and during treatment with the beta-receptor blocking drug metipranolol International Journal of Clinical Pharmacology Therapy and Toxicology 20(10): 469-473
Shigetomi, S.; Hashimoto, S.; Fukuchi, S. 1982: The role of sympathetic beta-adrenergic receptor on renin secretion in essential hypertension Nihon Jinzo Gakkai Shi 24(8): 929-936
Kanatu, K. 1977: Clinical studies of hypertension in patients undergoing regular maintenance hemodialysis. 1) a comparison of hemodynamic data and plasma renin activity between responsive and resistant hypertension to regular dialysis alone. 2) Beta adrenergic blockade in resistant hypertension Nihon Jinzo Gakkai Shi 19(11): 871-881
Kucerová, V.; Peleska, J.; Linhartová, J.; Ort, J. 1977: Functional dependence of prostaglandin F2alpha concentration and plasma renin activity in essential hypertension Casopis Lekaru Ceskych 116(37): 1142-1148
Chodakowska, J.; Wocial, B.; Ignatowska-Switalska, H.; Knypl, K.; Brym, E.; Czerniewska, E.; Wacławek-Maczkowska, J.; Jabłońska-Skwiecińska, E.; Drygieniec, D.; Januszewicz, W. 1989: Effect of treatment with enalapril maleate on the levels of circulating catecholamines, beta endorphins, prostaglandins, and concentration of sodium in erythrocytes in patients with essential hypertension Polski Tygodnik Lekarski 44(12-13): 297-300
Hayduk, K.; Riegger, G.; Krause, D.K.; Kaufmann, W. 1974: Electrolyte balance, plasma renin concentration and reaction of blood pressure in patients with essential hypertension and control subjects during therapy with metolazone, a new diuretic Arzneimittel-Forschung 24(1): 104-107
Brown, M.J.; Causon, R.C.; Barnes, V.F.; Brennan, P.; Barnes, G.; Greenberg, G. 1985: Urinary catecholamines in essential hypertension: results of 24-hour urine catecholamine analyses from patients in the Medical Research Council trial for mild hypertension and from matched controls Quarterly Journal of Medicine 57(222): 637-651
Neftel, K.A.; Käser, H.E.; Vorkauf, H. 1984: Different effects of selective and nonselective beta adrenoceptor blockade on urinary catecholamine and creatinine excretion in stress International Journal of Clinical Pharmacology Therapy and Toxicology 22(2): 118-119
Walter, I.; Kusus, T.; Wagner, K.; Lydtin, H. 1973: Effect of a beta receptor blocker on cardiac output--studies in essential hypertension and hyperkinetic heart syndrome with reference to plasma adrenaline and noradrenaline levels Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1010-1013
Kuchel, O.; Buu, N.T.; Hamet, P.; Larochelle, P.; Bourque, M.; Genest, J. 1984: Catecholamine sulfates and platelet phenolsulfotransferase activity in essential hypertension Journal of Laboratory and Clinical Medicine 104(2): 238-244
Wernze, H.; Hilfenhaus, M.; Rietbrock, I.; Schüttke, R.; Kühn, K. 1975: Plasma renin activity and plasma aldosterone during anaesthesia and operative stress and beta-adrenergic blockade Der Anaesthesist 24(11): 471-476
De Leeuw, P.W.; Birkenhäger, W.H. 1983: Alpha-adrenergic blockade in the treatment of essential hypertension Netherlands Journal of Medicine 26(9): 274-282
Parfitt, A.; Weller, J.L.; Klein, D.C.; Sakai, K.K.; Marks, B.H. 1975: Blockade by ouabain or elevated potassium ion concentration of the adrenergic and adenosine cyclic 3',5'-monophosphate-induced stimulation of pineal serotonin N-acetyltransferase activity Molecular Pharmacology 11(3): 241-255
Jin, H.K. 1983: Plasma catecholamine in primary hypertension Zhonghua Xin Xue Guan Bing Za Zhi 11(4): 273-277